TA148

Lung cancer (non-small-cell) - bevacizumab (terminated appraisal) (TA148)

  • Technology appraisals TA148
  • Issued: June 2008
    • Pathways

      lung cancer

      Fast, easy summary view of NICE guidance on 'lung cancer'

    • Bevacizumab for the treatment of non-small-cell lung cancer

      NICE is unable to recommend the use in the NHS of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with unresectable advanced, metastatic or recurrent non-small-cell lung cancer (other than predominantly squamous cell histology) because no evidence submission was received from the manufacturer or sponsor of the technology.

      • Other information

        NICE Pathways

        This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.

        Visit the NICE Pathway: lung cancer

        How this guidance was produced

        Background information

        • None found

      This page was last updated: 29 March 2012

    • Guidance formats

      Query

Implementation tools and resources

  • None available

See this guidance in practice

Patient

The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.

Quick Reference Guide

The quick reference guide presents recommendations for health professionals

NICE Guidance

The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.

Full Guidance

The published full clinical guidance for specialists with background, evidence, recommendations and methods used.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.